Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Nucl Med Biol. 2013 Apr 24;40(5):606–617. doi: 10.1016/j.nucmedbio.2013.01.011

Table 1.

MALs characterization.

MAL Peptide Sequence Formula Rt (min) RP-HPLC Mass Expected [M+H]+ Mass Observed [M+H]+
MAL0 DOTA(tBu)3 C28H52N4O8 -- 573.4 573.2
MAL1 DO3A(tBu)3-G- (D)S(tBu)-(D)S(tBu)-G- G-G-F C59H99N11O17 6.5 1234.7 1234.5
MAL2 DO3A(tBu)3-G- (D)S(tBu)-(D)S(tBu)-P- M-G-L-P C67H118N12O18S 9.8 1411.8 1411.5